These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Hymenolepis nana infection: associated factors with this parasitism in a health area of Southern Spain]. Cabeza MI; Cabezas MT; Cobo F; Salas J; Vázquez J Rev Chilena Infectol; 2015 Oct; 32(5):593-5. PubMed ID: 26633122 [TBL] [Abstract][Full Text] [Related]
23. Hymenolepis nana in a renal transplant recipient: to treat or not to treat? Syafinaz AN; Hamat RA; Malina O; Siti NM; Niazlin MT; Jamal F Med J Malaysia; 2011 Aug; 66(3):259-60. PubMed ID: 22111454 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of Shahnazi M; Mehrizi MZ; Alizadeh SA; Heydarian P; Saraei M; Alipour M; Hajialilo E Afr Health Sci; 2019 Mar; 19(1):1346-1352. PubMed ID: 31148960 [TBL] [Abstract][Full Text] [Related]
25. Action of homologous antiserum in vitro against life cycle stages of Hymenolepis nana, the dwarf mouse tapeworm. HEYNEMAN D; WELSH JF Exp Parasitol; 1959 Apr; 8(2):119-28. PubMed ID: 13653071 [No Abstract] [Full Text] [Related]
26. [Disinfestation of Hymenolepis nana with an aeridine derivative (Acranil Bayer)]. Marinoni V; Sperzani GL Arch Ital Sci Med Trop Parassitol; 1966; 47(11):327-30. PubMed ID: 5998347 [No Abstract] [Full Text] [Related]
27. Immunization of rodents against Hymenolepis infections using non-viable homologous oncospheres. Fan PC; Chung WC; Ito A Kaohsiung J Med Sci; 2004 Dec; 20(12):575-9. PubMed ID: 15696786 [TBL] [Abstract][Full Text] [Related]
29. The prevalence of Hymenolepis nana among preschool children of displacement communities in Khartoum state, Sudan: a cross-sectional study. Abdel Hamid MM; Eljack IA; Osman MK; Elaagip AH; Muneer MS Travel Med Infect Dis; 2015; 13(2):172-7. PubMed ID: 25586647 [TBL] [Abstract][Full Text] [Related]
30. [Epileptoid seizures during hymenolepiasis induced by dwarf tapeworms]. GORDADZE GN; GIGITASHVILI MS Med Parazitol (Mosk); 1959; 28():430-4. PubMed ID: 13851147 [No Abstract] [Full Text] [Related]
31. Coinfection with Pérez-Chacón G; Pocaterra LA; Rojas E; Hernán A; Jiménez JC; Núñez L Am J Trop Med Hyg; 2017 May; 96(5):1094-1096. PubMed ID: 28219994 [TBL] [Abstract][Full Text] [Related]
32. Control of Hymenolepis nana infection as a measure to improve mouse colony welfare. Dovč A; Gregurić Gračner G; Tomažič I; Vlahović K; Pavlak M; Lindtner Knific R; Kralj K; Stvarnik M; Vergles Rataj A Acta Vet Hung; 2017 Jun; 65(2):208-220. PubMed ID: 28605969 [TBL] [Abstract][Full Text] [Related]
33. Mixed Hymenolepis species infection in two family members: a case report from an urban area of Chilpancingo, Guerrero, México. Alvarez-Fernández BE; Rodríguez-Bataz E; Díaz-Chiguer DL; Márquez-Navarro A; Sánchez-Manzano RM; Nogueda-Torres B Trop Gastroenterol; 2012; 33(1):83-4. PubMed ID: 22803308 [No Abstract] [Full Text] [Related]
34. Cytokine production in Hymenolepis nana infection. Ajami A; Rafiei A Iran J Immunol; 2007 Dec; 4(4):236-40. PubMed ID: 18057582 [TBL] [Abstract][Full Text] [Related]
35. Mirazid in treatment of human hymenolepiasis. Massoud AM; Shazly AM; Shahat SA; Morsy TA J Egypt Soc Parasitol; 2007 Dec; 37(3):863-76. PubMed ID: 18383789 [TBL] [Abstract][Full Text] [Related]